Press Release

India Respiratory Inhalers Market to Grow with a CAGR of 7.45% through 2030

Increasing adoption of smart inhalers technologies and increasing prevalence of respiratory disorders is expected to drive the India Respiratory Inhalers Market growth in the forecast period, 2026-2030.


According to TechSci Research report, “India Respiratory Inhalers Market -Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030”, the India Respiratory Inhalers Market stood at USD 314.11 Million in 2024 and is anticipated to grow with a CAGR of 7.45% in the forecast period, 2026-2030. Several factors are bolstering the growth of the respiratory inhalers market in India. The increasing prevalence of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) is driving demand. The availability and accessibility of advanced inhaler devices, particularly in urban areas, are playing a significant role. The rise in healthcare expenditure and awareness about the benefits of inhalers is influencing market growth. Ongoing medical advancements in inhaler technology, coupled with strong governmental support for healthcare initiatives, are contributing to the market's expansion.


Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "India Respiratory Inhalers Market


The Respiratory Inhalers Market in India has been witnessing a significant surge in recent years, driven by an increase in the prevalence of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). This rise in respiratory conditions can be attributed to various factors, including environmental pollution, occupational hazards, and lifestyle choices. As urbanization continues to accelerate, more individuals are exposed to air pollution, which further exacerbates respiratory issues. India, with its vast population, presents a substantial market for respiratory inhalers. The rising awareness about the benefits of inhalers and their convenience over traditional medication methods has fueled their adoption. Patients and medical practitioners alike recognize the advantages of inhalers, such as targeted drug delivery and immediate relief of symptoms. Furthermore, advancements in medical technology have led to the development of more efficient and user-friendly inhalers, expanding their acceptance among patients.

In addition to the growing demand for respiratory inhalers, the Indian government has taken proactive measures to enhance healthcare infrastructure and increase healthcare accessibility. Initiatives such as tobacco control programs and national health missions have been launched to tackle respiratory diseases and promote preventive measures. These efforts have played a significant role in driving up the demand for respiratory inhalers in the market. However, despite the positive growth trajectory, the market still faces challenges. The high cost of inhalers remains a barrier to access for a significant portion of the Indian population, particularly in rural areas. Additionally, the lack of sufficient healthcare facilities and a lack of awareness among the rural population further hinder market growth. Addressing these challenges requires collaborative efforts from the government, healthcare providers, and pharmaceutical companies to make respiratory inhalers more affordable and accessible to all segments of society. Nevertheless, the future of the respiratory inhalers market in India looks promising. With constant efforts from the government and private players to curb respiratory diseases, along with technological advancements that make inhalers more affordable and accessible, the market is set to continue its upward trajectory. The increasing incidence of respiratory diseases, growing awareness, and favorable government initiatives create a conducive environment for the growth of the respiratory inhalers market. Despite the challenges, the respiratory inhalers market in India is poised for substantial growth. With an increase in the incidence of respiratory diseases, growing awareness, government initiatives, and technological advancements, the demand for these life-saving devices is predicted to rise significantly in the foreseeable future. As such, it presents substantial opportunities for players in the healthcare sector, both domestic and international, to contribute to the improvement of respiratory health in India.

The India Respiratory Inhalers Market is segmented into product type, technology, disease indication, distribution channel, end user, regional distribution, and company.

Based on disease indication, Chronic Obstructive Pulmonary Disease (COPD) is expected to be the fastest growing segment in the Indian Respiratory Inhalers Market. The prevalence of COPD in India is increasing, primarily due to high smoking rates and exposure to indoor and outdoor air pollutants. These factors contribute to the growing burden of COPD in the country. With a high patient population and increasing awareness about the disease, the demand for inhalation therapies is also on the rise. Inhalers have become an essential treatment option for COPD management, offering targeted delivery of medication directly to the lungs. This availability of effective inhalation therapies further solidifies COPD's position at the forefront of the Respiratory Inhalers Market in India. As the healthcare sector continues to evolve and advancements in the field of respiratory medicine are made, the Respiratory Inhalers Market in India is expected to witness continuous growth. The focus on improving patient outcomes and quality of life through innovative inhalation therapies will further drive the market's expansion, ensuring that COPD remains a key consideration for healthcare professionals and patients alike.

Based on region, Northern India is the fastest growing region in the India Respiratory Inhalers Market. Northern India is densely populated and includes major cities like Delhi, Chandigarh, Jaipur, and Lucknow. These urban centers experience rapid population growth and increasing urbanization, which often correlates with higher incidences of respiratory diseases due to pollution and lifestyle factors. Northern India, particularly in and around cities like Delhi and its neighboring areas, faces severe air pollution issues. Poor air quality is a significant contributor to respiratory illnesses such as asthma and chronic obstructive pulmonary disease (COPD), necessitating the use of respiratory inhalers. Northern India has a higher prevalence of respiratory diseases compared to other regions. Factors like environmental pollution, occupational hazards, and genetic predispositions contribute to a higher incidence of conditions like asthma and COPD. The healthcare infrastructure in Northern India has been improving, leading to better diagnosis and treatment of respiratory disorders. Increased awareness among both healthcare providers and patients about respiratory health and the availability of inhaler therapies have likely contributed to higher market growth. The economic growth and rising middle-class population in Northern India have led to increased healthcare spending, including on medications like respiratory inhalers. This economic prosperity often translates into higher access to healthcare facilities and medicines.


Major companies operating in India Respiratory Inhalers Market are:

  • Philips India Limited
  • Cipla Limited
  • Teva API India Limited
  • AstraZeneca Pharma India Limited
  • GlaxoSmithKline Pharmaceuticals Limited
  • Omron Healthcare India Private Limited
  • Novartis India Limited
  • 3M India Limited
  • Glenmark Pharmaceuticals Limited
  • Merck Life Science Private Limited


Download Free Sample Report

Customers can also request for 10% free customization on this report


“The future of the Indian Respiratory Inhalers Market appears to be promising. As pollution levels continue to rise and the incidence of respiratory disorders surges, the demand for respiratory inhalers is expected to witness substantial growth. Furthermore, the increasing awareness among individuals regarding the availability of advanced medical treatments and the government's active initiatives aimed at enhancing healthcare infrastructure are also playing pivotal roles in driving the market's expansion. With these factors combined, the Indian Respiratory Inhalers Market is poised to experience significant development in the coming years.,” said Mr. Karan Chechi, Research Director of  TechSci Research, a research-based management consulting firm.

India Respiratory Inhalers Market By Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Others), By Technology (Manually Operated Inhalers, Digitally Operated Inhalers), By Disease Indication (COPD, Asthma, Pulmonary Atrial Hypertension, Others), By Distribution Channel (Online, Offline), By End User (Hospitals & Clinics, Homecare, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F”, has evaluated the future growth potential of India Respiratory Inhalers Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India Respiratory Inhalers Market.


TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]


Relevant News